| Allele Name | tm3496 |
| Balance | Not Required |
| OutCross | Not Accepted |
| Sequence Name | T05A6.2 |
| Gene Name | cki-2 |
| Worm Base | Allele Name |
tm3496
|
| Gene Name |
cki-2
|
| Sequence |
T05A6.2
|
Phenotype
Information from the receiver is posted in the form
of a "researcher : phenotype"
| homozygous viable. Dr. S. Boulton: 0.26% males, does not genetically interact with brd-1 (dw1). Dr. E.T. Kipreos: fertile, normal locomotion. |
Mutation site
Please see gene structure to locate the deletion in
relation to exon(s)
| 16368/16369-16730/16731 (362 bp deletion) |
| Chromosome | II |
| Putative gene structure | join(15101..15175, 15221..15546, 15590..15657, 16291..16453, 16511..16655) |
| Map position | 0.57 |
| Balancer | |
| Map position of balancer | |
| Sequence of primers | ExtFwd:AGACTTGCGTAAATCGGCTC,IntFwd:ACCGCCCGAACATCTGATTA,ExtRev:TGCCGCATCATGTTTCATGT,IntRev:CCGCTTTACACGAAATCGTT |
| Distributed lab | |
| Depositor | Dr. S. Mitani/NBRP |
| References |
Please submit your publication
Buck SH, Chiu D, Saito RM. The cyclin-dependent kinase inhibitors, cki-1 and cki-2, act in overlapping but distinct pathways to control cell cycle quiescence during C. elegans development. Cell Cycle 2009 8(16) 2613-20
[ PubMed ID = 19597327 ]
[ RRC reference ]
|
|